Excessive Rescue Inhaler Use Associated With Higher Cardiovascular Disease Risk
-
By
-
Debbie Bunch
-
November 3, 2026
Clinical Scorecard: Excessive Rescue Inhaler Use Associated With Higher Cardiovascular Disease Risk
At a Glance
| Category | Detail |
|---|---|
| Condition | Clinical topic addressed by the source article: Excessive Rescue Inhaler Use Associated With Higher Cardiovascular Disease Risk |
| Key Mechanisms | Mechanisms were not reported; the study assessed associations between SABA, SAMA, or combined SABA+SAMA use and cardiovascular outcomes and all-cause mortality. |
| Target Population | Patients or participants described in the source article. |
| Care Setting | Care setting described in the source article. |
Key Highlights
- Approximately 17% of patients with asthma and 30% of patients with COPD used at least 3 SABD canisters during the baseline year, classified as overuse.
- Compared with no use, SAMA and SABA+SAMA exposure was associated with higher heart failure, arrhythmia, and all-cause mortality risks in patients with asthma and COPD.
- Among patients with asthma, use of 1–2 or at least 3 SABA+SAMA canisters was associated with higher myocardial infarction and ischemic stroke risks.
- Among patients with COPD, use of at least 3 SABA+SAMA canisters was associated with a 1.4-fold higher myocardial infarction risk.
- Use of at least 3 SABA canisters was associated with 1.1-fold higher heart failure and mortality risks in both asthma and COPD; use of 1–2 SABA canisters was not associated with increased risks.
Guideline-Based Recommendations
Diagnosis
Management
- The authors state that monitoring SABD use is important in patients with asthma or COPD, even when cardiovascular disease has not been identified.
Monitoring & Follow-up
Risks
Patient & Prescribing Data
Nationwide Belgian cohort of 226,314 patients with asthma and 57,446 with COPD; exposure groups included users and nonusers of SABA, SAMA, and SABA+SAMA.
Exposure was assessed by canisters used during the baseline year. At least 3 SABD canisters was classified as overuse; this occurred in approximately 17% of patients with asthma and 30% of patients with COPD.
Clinical Best Practices
- Monitor SABD use in patients with asthma or COPD, including those without identified cardiovascular disease.
Related Resources & Content
Based on findings from:
Overuse of Rescue Inhalers Linked to Increased Risk for Cardiovascular Diseases
Debbie Bunch. American Association For Respiratory Care, 2026.
https://rccentral.aarc.org/overuse-of-rescue-inhalers-linked-to-increased-risk-for-cardiovascular-diseases/
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
